Understand Fulminant Liver Failure (Acute Liver Failure, Fulminant Hepatic Failure) with comprehensive information for healthcare professionals. This resource covers clinical documentation, medical coding, diagnosis, and treatment of Fulminant Liver Failure, supporting accurate and efficient healthcare practices. Learn about the causes, symptoms, and management of Acute Liver Failure and Fulminant Hepatic Failure for improved patient care and optimized clinical workflows.
Also known as
Acute and subacute liver failure
Covers acute and subacute liver failure, including fulminant hepatic failure.
Diseases of liver
Encompasses various liver diseases, including potential underlying causes of liver failure.
Unspecified jaundice
Jaundice is a common symptom of liver failure and can be coded if the cause is not yet determined.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the liver failure acute?
When to use each related code
| Description |
|---|
| Sudden, severe liver failure. |
| Sudden liver inflammation from drugs, toxins, or viruses. |
| Chronic liver damage leading to scarring and impaired function. |
Coding FHF without documenting the underlying cause (e.g., viral hepatitis, drug toxicity) leads to coding inaccuracies and impacts DRG assignment.
Misdiagnosis of acute vs. chronic liver failure can affect coding (e.g., K72.01 vs. I85.0), impacting reimbursement and quality metrics.
Failing to code associated complications (e.g., hepatic encephalopathy, coagulopathy) affects severity scores and resource utilization reflection.
Q: What are the key differentiating factors in diagnosing hyperacute, acute, and subacute liver failure, particularly considering the rapid progression often seen in fulminant hepatic failure?
A: Differentiating hyperacute, acute, and subacute liver failure hinges on the time interval between jaundice onset and hepatic encephalopathy. Hyperacute liver failure presents with encephalopathy within 7 days of jaundice, acute within 7-28 days, and subacute within 28 days to 12 weeks. Fulminant hepatic failure, often used interchangeably with acute liver failure, is characterized by rapid progression and severe complications, making early diagnosis crucial. Consider implementing a standardized assessment protocol incorporating King's College Criteria or the Clichy criteria for early identification and prognostication of acute liver failure, especially in cases with suspected fulminant hepatic failure. Explore how these criteria can be integrated into your practice to improve patient outcomes.
Q: How do I effectively manage a patient with suspected fulminant liver failure in the initial 24 hours, including essential investigations and stabilizing measures?
A: Managing suspected fulminant liver failure within the first 24 hours requires a multidisciplinary approach. Immediate stabilization focuses on airway, breathing, and circulation. Essential investigations include blood tests (liver function tests, coagulation profile, ammonia, blood glucose, electrolytes), arterial blood gas analysis, and imaging (ultrasound, CT scan) to determine the etiology and assess the severity. Closely monitor for signs of hepatic encephalopathy and cerebral edema. Initiate measures to prevent complications like infection and gastrointestinal bleeding. Consider implementing a structured management protocol and early referral to a specialist liver center for potential liver transplantation. Learn more about the critical role of early intervention in fulminant liver failure management.
Patient presents with acute liver failure (fulminant hepatic failure), characterized by rapid deterioration of liver function in a patient without pre-existing liver disease. Symptoms include hepatic encephalopathy manifesting as confusion, disorientation, and asterixis, along with jaundice, coagulopathy evidenced by prolonged INR, and ascites. Initial presentation included nausea, vomiting, and anorexia. Differential diagnoses considered included acute viral hepatitis, drug-induced liver injury, and autoimmune hepatitis. Laboratory findings reveal significantly elevated liver enzymes (AST, ALT), bilirubin, and ammonia levels. PT/INR is prolonged, suggesting impaired hepatic synthetic function. Abdominal ultrasound and CT scan were performed to evaluate liver morphology and rule out other causes of acute abdominal pain. The patient's rapid decline in hepatic function meets the criteria for fulminant liver failure, with hepatic encephalopathy developing within 8 weeks of initial symptom onset. Treatment plan includes intensive supportive care, monitoring for complications such as cerebral edema and sepsis, and evaluation for potential liver transplantation. Patient is being closely monitored for signs of worsening hepatic encephalopathy and multi-organ failure. Prognosis is guarded given the severity of the condition. ICD-10 code K72.0 is documented for acute and subacute hepatic failure. Medical billing codes will reflect the level of critical care provided, including intensive monitoring and management.